Skip to content

Osseodensification Versus Conventional Drilling Effect on Implant Stability

The Impact of Osseodensification and Conventional Drilling Protocols on Implants Mechanical and Biological Stability in Posterior Maxilla: A Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05824949
Enrollment
40
Registered
2023-04-24
Start date
2022-04-04
Completion date
2023-02-01
Last updated
2023-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implant Therapy

Brief summary

A total of 80 implants were placed in the posterior region of the maxilla in 40 patients in a split-mouth design. Bone quality was classified into type I, II, III, IV, or V as assessed preoperatively on cone-beam computed tomography (CBCT) . Primary implant stability was measured with insertion torque and resonance frequency analysis (ISQ values). Secondary stability was measured by ISQ at abutment installation.

Interventions

Implant mechanical and biological stability measured using ISQ values at the time of implant placement and at abutment connection for 40 implants placed in the posterior maxillary area using the osseodensification protocol.

Implant mechanical and biological stability measured using ISQ values at the time of implant placement and at abutment connection for 40 implants placed in the posterior maxillary area using the conventional drilling protocol.

Sponsors

Arab American University (Palestine)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* (a) Bilateral edentulism in the maxillary posterior region dating back more than 6 months, * (b) sufficient bone height (distance between the bone crest and maxillary sinus \>8 mm) and width at the alveolar crest (≥6 mm) that would not necessitate bone augmentation, * (c) at least 2 mm vestibular keratinized mucosa width and 3 mm mucosa thickness, * (d) full-mouth plaque and bleeding scores \<20%.

Exclusion criteria

* patients with systemic diseases, conditions, or used medications having the potential to impair surgery, bone, and wound healing dynamics (such as diabetes) will be excluded. * patients who are allergic to antibiotics and non-steroidal anti-inflammatory drugs * bone height \<8mm * ridge and soft tissue deficiencies requiring augmentation procedures and * endodontic or periodontal lesions neighboring the edentulous sites will be also excluded.

Design outcomes

Primary

MeasureTime frameDescription
Mechanical or primary stabilitydirectly after implant placementISQ values at implant installation
Biological or secondary stability4 months after implant installationISQ values at abutment connection

Secondary

MeasureTime frameDescription
Torque value (N/cm)directly after implant insertionTorque value shown at the physiodispenser screen at the end of implant installation

Countries

Palestinian Territories

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026